Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 3,071,340 | 1,350,826 | -1,720,514 | $23.50M | $114.69M | 11.36% | +$91.19M |
| Keros Therapeutics, Inc.(KROS) | 5,389,264 | 5,389,264 | 0 | $71.95M | $85.26M | 8.44% | +$13.31M |
| Protagonist Therapeutics Inc | 948,069 | 989,182 | +41,113 | $52.40M | $65.71M | 6.51% | +$13.31M |
| Roivant Sciences Ltd.SHS(ROIV) | 1,940,797 | 3,347,501 | +1,406,704 | $21.87M | $50.65M | 5.02% | +$28.77M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 337,125 | 337,125 | 0 | $37.99M | $38.39M | 3.80% | +$397.8K |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 22,684 | 54,684 | +32,000 | $14.02M | $36.43M | 3.61% | +$22.41M |
| Immunovant, Inc.(IMVT) | 535,066 | 2,241,753 | +1,706,687 | $8.56M | $36.14M | 3.58% | +$27.58M |
| 89bio Inc | 875,983 | 2,113,153 | +1,237,170 | $8.60M | $31.06M | 3.08% | +$22.46M |
| Zai Lab LimitedADR(ZLAB) | 850,437 | 868,780 | +18,343 | $29.74M | $29.44M | 2.92% | -$296.8K |
| Cytokinetics, Incorporated(CYTK) | 582,147 | 518,921 | -63,226 | $19.23M | $28.52M | 2.82% | +$9.29M |
| Septerna, Inc.(SEPN) | 847,227 | 1,176,491 | +329,264 | $8.96M | $22.13M | 2.19% | +$13.17M |
| Prothena Corp PlcSHS SHS | 3,375,009 | 1,469,098 | -1,905,911 | $20.49M | $14.34M | 1.42% | -$6.15M |
| BridgeBio Pharma, Inc.(BBIO) | 259,659 | 273,414 | +13,755 | $11.21M | $14.20M | 1.41% | +$2.99M |
| Arbutus Biopharma Corporation(ABUS) | 2,825,773 | 2,903,226 | +77,453 | $8.73M | $13.18M | 1.31% | +$4.45M |
| Rapt Therapeutics Inc | 783,217 | 507,771 | -275,446 | $6.27M | $13.10M | 1.30% | +$6.83M |
| CytomX Therapeutics, Inc.(CTMX) | 3,081,414 | 4,045,414 | +964,000 | $6.99M | $12.90M | 1.28% | +$5.91M |
| Spdr Series TrustBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 135,585 | 135,585 | 0 | $12.44M | $12.44M | 1.23% | +$2.7K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 1,205,101 | 866,202 | -338,899 | $7.72M | $11.77M | 1.17% | +$4.05M |
| BioAge Labs, Inc.(BIOA) | 1,937,123 | 1,880,073 | -57,050 | $8.00M | $11.05M | 1.09% | +$3.05M |
| Monopar Therapeutics Inc.(MNPR) | 100,974 | 129,999 | +29,025 | $3.61M | $10.62M | 1.05% | +$7.00M |
| Crinetics Pharmaceuticals In | 53,125 | 248,368 | +195,243 | $1.53M | $10.34M | 1.02% | +$8.82M |
| Lexeo Therapeutics, Inc.(LXEO) | 145,109 | 1,531,953 | +1,386,844 | $583.3K | $10.17M | 1.01% | +$9.59M |
| CG Oncology, Inc.(CGON) | 523,216 | 248,917 | -274,299 | $13.60M | $10.03M | 0.99% | -$3.58M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,009,870 | 2,835,680 | -174,190 | $6.95M | $9.27M | 0.92% | +$2.32M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 3,361 | 15,700 | +12,339 | $1.76M | $8.83M | 0.87% | +$7.06M |
| Ionis Pharmaceuticals, Inc.(IONS) | 148,461 | 133,818 | -14,643 | $5.87M | $8.75M | 0.87% | +$2.89M |
| Janux Therapeutics, Inc.(JANX) | 62,088 | 351,032 | +288,944 | $1.43M | $8.58M | 0.85% | +$7.14M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,122,105 | 5,247,603 | +125,498 | $9.99M | $8.50M | 0.84% | -$1.49M |
| Invivyd, Inc.(IVVD) | 0 | 7,370,987 | +7,370,987 | $0 | $8.11M | 0.80% | +$8.11M |
| Metsera Inc | 0 | 152,521 | +152,521 | $0 | $7.98M | 0.79% | +$7.98M |
| Equillium, Inc.(EQ) | 0 | 5,559,988 | +5,559,988 | $0 | $7.95M | 0.79% | +$7.95M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.96M | $7.92M | 0.78% | -$45.0K |
| uniQure N.V.SHS(QURE) | 0 | 133,316 | +133,316 | $0 | $7.78M | 0.77% | +$7.78M |
| Vaxcyte, Inc.(PCVX) | 98,032 | 213,064 | +115,032 | $3.19M | $7.67M | 0.76% | +$4.49M |
| Rezolute, Inc.(RZLT) | 989,297 | 815,975 | -173,322 | $4.41M | $7.67M | 0.76% | +$3.26M |
| Xenon Pharmaceuticals Inc.(XENE) | 259,503 | 189,098 | -70,405 | $8.12M | $7.59M | 0.75% | -$530.2K |
| Ascendis Pharma A/SADR(ASND) | 1,402 | 36,345 | +34,943 | $242.0K | $7.23M | 0.72% | +$6.98M |
| Savara Inc.(SVRA) | 3,600,670 | 1,988,288 | -1,612,382 | $8.21M | $7.10M | 0.70% | -$1.11M |
| Sarepta Therapeutics, Inc.(SRPT) | 210,313 | 349,807 | +139,494 | $3.60M | $6.74M | 0.67% | +$3.14M |
| Revolution Medicines, Inc.(RVMD) | 134,136 | 139,136 | +5,000 | $4.93M | $6.50M | 0.64% | +$1.56M |
| Aa Mission Acquisition CorpCL A | 578,359 | 578,359 | 0 | $6.03M | $6.08M | 0.60% | +$57.8K |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 501,228 | +501,228 | $0 | $5.80M | 0.57% | +$5.80M |
| Verona Pharma PlcADS | 28,450 | 51,450 | +23,000 | $2.69M | $5.49M | 0.54% | +$2.80M |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 516,482 | 516,482 | 0 | $5.48M | $5.48M | 0.54% | $0 |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 345,878 | 267,816 | -78,062 | $5.80M | $5.41M | 0.54% | -$387.0K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 45,390 | 49,571 | +4,181 | $2.87M | $5.01M | 0.50% | +$2.14M |
| Atai Life Sciences NvSHS | 0 | 913,242 | +913,242 | $0 | $4.83M | 0.48% | +$4.83M |
| United Therapeutics Corporation(UTHR) | 0 | 11,200 | +11,200 | $0 | $4.70M | 0.46% | +$4.70M |
| Viking Therapeutics, Inc.(VKTX) | 67,813 | 175,919 | +108,106 | $1.80M | $4.62M | 0.46% | +$2.83M |
| BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO) | 0 | 0 | 0 | $4.19M | $4.45M | 0.44% | +$257.6K |
| Replimune Group, Inc.(REPL) | 10,400 | 978,894 | +968,494 | $96.6K | $4.10M | 0.41% | +$4.00M |
| Nektar Therapeutics(NKTR) | 15,796 | 72,007 | +56,211 | $408.2K | $4.10M | 0.41% | +$3.69M |
| Establishment Labs Holdings Inc.(ESTA) | 25,000 | 90,688 | +65,688 | $1.07M | $3.72M | 0.37% | +$2.65M |
| SanofiADR(SNY) | 10,000 | 74,212 | +64,212 | $483.1K | $3.50M | 0.35% | +$3.02M |
| Krystal Biotech, Inc.(KRYS) | 0 | 18,523 | +18,523 | $0 | $3.27M | 0.32% | +$3.27M |
| Newamsterdam Pharma Company ORDINARY SHARES | 112,359 | 114,359 | +2,000 | $2.03M | $3.25M | 0.32% | +$1.22M |
| Fulcrum Therapeutics, Inc.(FULC) | 53,349 | 341,612 | +288,263 | $367.0K | $3.14M | 0.31% | +$2.78M |
| Merus N V | 18,313 | 33,313 | +15,000 | $963.3K | $3.14M | 0.31% | +$2.17M |
| Mineralys Therapeutics, Inc.(MLYS) | 302,125 | 78,238 | -223,887 | $4.09M | $2.97M | 0.29% | -$1.12M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 56,540 | 75,187 | +18,647 | $1.56M | $2.92M | 0.29% | +$1.36M |
| Celldex Therapeutics, Inc.(CLDX) | 57,466 | 109,442 | +51,976 | $1.17M | $2.83M | 0.28% | +$1.66M |
| Zura Bio LimitedCL A(ZURA) | 997,547 | 652,154 | -345,393 | $1.05M | $2.82M | 0.28% | +$1.78M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $2.49M | $2.81M | 0.28% | +$324.3K |
| Vertex Pharmaceuticals Incorporated(VRTX) | 0 | 7,000 | +7,000 | $0 | $2.74M | 0.27% | +$2.74M |
| Arcellx Inc COMMON STOCK | 13,962 | 31,484 | +17,522 | $919.4K | $2.58M | 0.26% | +$1.67M |
| Biogen Inc.(BIIB) | 5,100 | 18,000 | +12,900 | $640.5K | $2.52M | 0.25% | +$1.88M |
| Delcath Systems, Inc.(DCTH) | 149,385 | 224,385 | +75,000 | $2.03M | $2.41M | 0.24% | +$380.5K |
| Avidity Biosciences Inc | 0 | 53,656 | +53,656 | $0 | $2.34M | 0.23% | +$2.34M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,054 | 4,895 | +3,841 | $319.0K | $2.25M | 0.22% | +$1.93M |
| A Spac Iii Acquisition CorpCL A ORD SHS CL A | 215,000 | 215,000 | 0 | $2.20M | $2.22M | 0.22% | +$19.4K |
| Masimo Corp | 0 | 15,000 | +15,000 | $0 | $2.21M | 0.22% | +$2.21M |
| Viridian Therapeutics, Inc.(VRDN) | 170,598 | 101,704 | -68,894 | $2.38M | $2.19M | 0.22% | -$190.2K |
| Summit Therapeutics Inc.(SMMT) | 12,000 | 102,969 | +90,969 | $255.4K | $2.13M | 0.21% | +$1.87M |
| Cidara Therapeutics Inc | 21,522 | 21,522 | 0 | $1.05M | $2.06M | 0.20% | +$1.01M |
| REGENXBIO Inc.(RGNX) | 207,818 | 205,409 | -2,409 | $1.71M | $1.98M | 0.20% | +$276.0K |
| Korro Bio, Inc.(KRRO) | 68,815 | 40,235 | -28,580 | $859.5K | $1.93M | 0.19% | +$1.07M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 275,800 | 575,800 | +300,000 | $675.7K | $1.88M | 0.19% | +$1.20M |
| OmniAb, Inc.(OABI) | 326,108 | 1,090,628 | +764,520 | $567.4K | $1.75M | 0.17% | +$1.18M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 55,200 | 49,800 | -5,400 | $872.2K | $1.72M | 0.17% | +$845.4K |
| Soleno Therapeutics Inc | 17,330 | 25,230 | +7,900 | $1.45M | $1.71M | 0.17% | +$253.6K |
| Dynavax Technologies Corp | 170,000 | 170,000 | 0 | $1.69M | $1.69M | 0.17% | +$1.7K |
| Alkermes plcSHS(ALKS) | 45,000 | 56,200 | +11,200 | $1.29M | $1.69M | 0.17% | +$398.6K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 215,752 | +215,752 | $0 | $1.60M | 0.16% | +$1.60M |
| Merck & Co., Inc.(MRK) | 7,040 | 18,540 | +11,500 | $557.3K | $1.56M | 0.15% | +$998.8K |
| Cohen Circle Acquisit Corp IUNIT 07 01 2030 UNIT 07/01/2030 | 0 | 150,000 | +150,000 | $0 | $1.54M | 0.15% | +$1.54M |
| Acumen Pharmaceuticals, Inc.(ABOS) | 916,183 | 891,183 | -25,000 | $1.06M | $1.52M | 0.15% | +$461.2K |
| Xencor, Inc.(XNCR) | 85,826 | 128,865 | +43,039 | $674.6K | $1.51M | 0.15% | +$837.0K |
| Agios Pharmaceuticals, Inc.(AGIO) | 35,900 | 37,000 | +1,100 | $1.19M | $1.49M | 0.15% | +$291.1K |
| WW International, Inc.(WW) | 0 | 52,450 | +52,450 | $0 | $1.44M | 0.14% | +$1.44M |
| Astria Therapeutics Inc | 249,646 | 193,934 | -55,712 | $1.34M | $1.41M | 0.14% | +$73.7K |
| Centessa Pharmaceuticals PlcADS | 296,766 | 53,666 | -243,100 | $3.90M | $1.30M | 0.13% | -$2.60M |
| IRulya Therapeutics Inc.(IRLA) | 142,958 | 775,034 | +632,076 | $235.9K | $1.26M | 0.13% | +$1.03M |
| Pfizer Inc.(PFE) | 39,400 | 44,400 | +5,000 | $955.1K | $1.13M | 0.11% | +$176.3K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 34,314 | 151,495 | +117,181 | $1.62M | $1.09M | 0.11% | -$533.4K |
| Grace Therapeutics, Inc.(GRCE) | 176,627 | 350,450 | +173,823 | $524.6K | $1.04M | 0.10% | +$518.7K |
| Nuvalent Inc | 11,842 | 11,842 | 0 | $903.5K | $1.02M | 0.10% | +$120.6K |
| BEST SPAC I Acquisition Corp.UNIT 05 27 2030(BSAA) | 100,000 | 100,000 | 0 | $1.00M | $1.02M | 0.10% | +$12.0K |
| Electronic Arts Inc | 0 | 4,936 | +4,936 | $0 | $995.6K | 0.10% | +$995.6K |
| BioNTech SEADS(BNTX) | 0 | 10,000 | +10,000 | $0 | $986.2K | 0.10% | +$986.2K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 166,799 | 77,961 | -88,838 | $662.2K | $916.0K | 0.09% | +$253.8K |